1,089 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
of Augtyro in the fourth quarter of 2023.
On a GAAP basis, income tax expense was $392 million on a pre-tax loss of $11.5 billion and on a non-GAAP basis … , income tax expense was $732 million on a pre-tax loss of $8.2 billion primarily due to the $12.1 billion one-time, non-tax-deductible charge
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
of Acquired Intangibles 2.4 2.3 - - Effective Tax Rate (3.4%) 18.2% (9.0%) 15.5% Diluted EPS (5.89) 1.07 (4.40) 2.05 Diluted Shares Outstanding … % ~74% No Change Operating Expenses1 Low single-digit increase No Change Other Income/(Expense) ~$250M ~($250M) Tax Rate ~17.5% ~69% Diluted EPS2 $7.10
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
stock options. Even after the respective multiple is satisfied, Section 16 Officers are required to hold 75% of all newly acquired net after-tax
8-K
EX-1.1
bastqnn 6n8i9cvtl
22 Feb 24
Other Events
4:15pm
8-K
EX-4.1
o9hg4h
22 Feb 24
Other Events
4:15pm
424B5
xt0v777tasyt
16 Feb 24
Prospectus supplement for primary offering
4:34pm
8-K
sqmtb51
15 Feb 24
Departure of Directors or Certain Officers
4:57pm
FWP
8xy b2whj5c2w9
14 Feb 24
Free writing prospectus
9:07pm